Editorial & Opinion
RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.
العنوان: | RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer. |
---|---|
المؤلفون: | Huynh MM; Phoenix Molecular Designs, Vancouver, British Columbia, Canada., Jayanthan A; Phoenix Molecular Designs, Vancouver, British Columbia, Canada., Pambid MR; Phoenix Molecular Designs, Vancouver, British Columbia, Canada., Los G; Phoenix Molecular Designs, San Diego, CA, USA., Dunn SE; Phoenix Molecular Designs, Vancouver, British Columbia, Canada.; Phoenix Molecular Designs, San Diego, CA, USA. |
المصدر: | Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2020 Jan; Vol. 24 (1), pp. 1-5. Date of Electronic Publication: 2019 Dec 27. |
نوع المنشور: | Editorial |
اللغة: | English |
بيانات الدورية: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101127833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7631 (Electronic) Linking ISSN: 14728222 NLM ISO Abbreviation: Expert Opin Ther Targets Subsets: MEDLINE |
أسماء مطبوعة: | Publication: London : Informa Healthcare Original Publication: London : Ashley Publications, c2001- |
مواضيع طبية MeSH: | Molecular Targeted Therapy*, Ribosomal Protein S6 Kinases, 90-kDa/*antagonists & inhibitors , Triple Negative Breast Neoplasms/*drug therapy, Animals ; Female ; Humans ; Protein Kinase Inhibitors/pharmacology ; Ribosomal Protein S6 Kinases, 90-kDa/metabolism ; Triple Negative Breast Neoplasms/pathology |
فهرسة مساهمة: | Keywords: Kinase inhibitors; RSK2; targeted therapy; triple-negative breast cancer (TNBC) |
المشرفين على المادة: | 0 (Protein Kinase Inhibitors) EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 90-kDa) EC 2.7.11.1 (ribosomal protein S6 kinase, 90kDa, polypeptide 3) |
تواريخ الأحداث: | Date Created: 20191227 Date Completed: 20210205 Latest Revision: 20210205 |
رمز التحديث: | 20240829 |
DOI: | 10.1080/14728222.2020.1709824 |
PMID: | 31875730 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1744-7631 |
---|---|
DOI: | 10.1080/14728222.2020.1709824 |